• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Clinical Trials

Posted inClinical Trials, Infections, New Drugs, Regulatory

Hepcludex: Effective Treatment for Chronic Hepatitis D

by Julia Mardi July 18, 2022September 8, 2022

Bulevirtide is the only approved antiviral drug against hepatitis delta.

weight-loss-pills
Posted inClinical Trials, In the Pipeline, Metabolism

Most Effective Weight Loss Drugs: Present and Future

by Julia Mardi and Timur Burkhanayev July 3, 2022September 20, 2022

Modern pharmacological ways to combat obesity.

Posted inClinical Trials, Neuroscience, Rare/Orphan Diseases

Alsitek: New Drug for ALS

by Mark Gubar and Julia Mardi June 17, 2022September 8, 2022

Oral masitinib doubles the life in patients with amyotrophic lateral sclerosis.

olorofim
Posted inClinical Trials, Infections, Rare/Orphan Diseases

Olorofim: New Antifungal Drug

by Tanya von Reuss June 9, 2022September 8, 2022

Olorophim by F2G and Shionogi & Co. is focused on invasive aspergillosis treatment.

obesity
Posted inClinical Trials, Metabolism

Tirzepatide: Strong Weight-Loss Drug

by Tanya von Reuss June 6, 2022September 8, 2022

Losing 24 kilograms in a year and a half.

brain
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Ublyxi: Highly Effective Drug for Multiple Sclerosis

by Julia Mardi May 31, 2022September 8, 2022

Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.

Posted inClinical Trials, Infections

Ycanth: First Treatment for Molluscum Contagiosum and Warts

by Tanya von Reuss May 25, 2022September 8, 2022

Cantharidin Verrica Pharmaceuticals can help get rid of common viral skin lesions.

Posts pagination

Newer posts 1 2 3 4 5 … 7 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×